Enimmune corporation (6564.TWO)
TWD 26.45
(-0.75%)
TWD 26.45
(-0.75%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 45.73 Million TWD | 54.03% |
| 2022 | 29.69 Million TWD | 267.38% |
| 2021 | 8.08 Million TWD | -32.68% |
| 2020 | 12 Million TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 102.05 Million TWD | 0.0% |
| 2024 Q1 | - TWD | -100.0% |
| 2023 Q3 | 43.89 Million TWD | -7.99% |
| 2023 FY | 45.73 Million TWD | 54.03% |
| 2023 Q2 | 47.7 Million TWD | 4.0% |
| 2023 Q1 | 45.86 Million TWD | 54.48% |
| 2023 Q4 | 45.73 Million TWD | 4.2% |
| 2022 FY | 29.69 Million TWD | 267.38% |
| 2022 Q4 | 29.69 Million TWD | 6.66% |
| 2022 Q3 | 27.83 Million TWD | 0.0% |
| 2021 FY | 8.08 Million TWD | -32.68% |
| 2020 FY | 12 Million TWD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Bio Preventive Medicine Corp. | 113.44 Million TWD | 59.687% |
| Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | 83.874% |
| Advagene Biopharma Co., Ltd. | 870 Thousand TWD | -5156.782% |
| Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | 82.975% |
| NaviFUS Corp. | 32.69 Million TWD | -39.889% |
| G&E Herbal Biotechnology Co., Ltd. | 5.43 Million TWD | -742.092% |
| TaiRx, Inc. | 12.28 Million TWD | -272.245% |
| Sinew Pharma Inc. | 6.46 Million TWD | -607.519% |
| Lin BioScience, Inc. | 42.87 Million TWD | -6.673% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 1.17 Million TWD | -3805.551% |
| Lumosa Therapeutics Co., Ltd. | 12.61 Million TWD | -262.68% |
| Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | -3206.869% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | 88.645% |
| AP Biosciences Inc | 82.07 Million TWD | 44.281% |
| Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | 73.729% |
| RBC Bioscience Corporation | 487.36 Million TWD | 90.616% |
| Syngen Biotech Co.,Ltd. | 681.76 Million TWD | 93.292% |
| EirGenix Inc. | 465.16 Million TWD | 90.168% |
| Lukas Biomedical Inc. | 82.55 Million TWD | 44.602% |
| BRIM Biotechnology, Inc. | 3.59 Million TWD | -1173.218% |
| 3D Global Biotech Inc. | 10.37 Million TWD | -340.64% |
| TaiMed Biologics Inc. | 750.85 Million TWD | 93.909% |
| Mycenax Biotech Inc. | 726.27 Million TWD | 93.703% |
| TCI GENE Inc. | 6.79 Million TWD | -573.054% |
| SynCore Biotechnology Co.,Ltd | 2.11 Million TWD | -2063.387% |
| Oneness Biotech Co., Ltd. | 397.95 Million TWD | 88.508% |
| Eusol Biotech Co.,Ltd. | 4.35 Million TWD | -950.39% |
| Feng Chi Biotech Corp. | 10.79 Million TWD | -323.541% |
| NeoCore Technology Co., Ltd. | 96.89 Million TWD | 52.799% |
| TWi Biotechnology, Inc. | 7.97 Million TWD | -473.755% |
| Neith Corporation | 3.54 Million TWD | -1191.556% |
| Sunny Pharmtech Inc. | 391.42 Million TWD | 88.316% |
| VBI | - TWD | -Infinity% |
| Ever Supreme Bio Technology Co., Ltd | 5.89 Million TWD | -675.415% |
| GeneReach Biotechnology Corp. | 257.03 Million TWD | 82.207% |
| Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -8400.743% |
| CHO Pharma, Inc. | - TWD | -Infinity% |
| Andros Pharmaceuticals Co.,Ltd | 27.12 Million TWD | -68.629% |
| MegaPro Biomedical Co., Ltd | 8.31 Million TWD | -449.82% |
| Visgeneer Inc. | 158.6 Million TWD | 71.165% |
| Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | 76.682% |
| BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | 21.427% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | 89.033% |
| Sagittarius Life Science Corp | 13.32 Million TWD | -243.271% |
| BioGend Therapeutics Co., Ltd. | 13.09 Million TWD | -249.328% |
| GlycoNex Incorporation | 900 Thousand TWD | -4981.556% |
| Medigen Biotechnology Corp. | 2.91 Billion TWD | 98.429% |
| Pharmosa Biopharm Inc. | 144.36 Million TWD | 68.321% |
| PharmaEngine, Inc. | 14.8 Million TWD | -208.826% |
| Intech Biopharm Corporation | 1.43 Billion TWD | 96.813% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | 85.714% |
| BiOptic Inc. | 93.19 Million TWD | 50.928% |
| TaiGen Biopharmaceuticals Holdings Limited | 74.68 Million TWD | 38.766% |
| Senhwa Biosciences, Inc. | 9.6 Million TWD | -376.346% |
| NatureWise Biotech & Medicals Corporation | 10.68 Million TWD | -328.141% |
| OBI Pharma, Inc. | 501.05 Million TWD | 90.872% |
| Savior Lifetec Corporation | 270.37 Million TWD | 83.085% |
| Great Novel Therapeutics Biotech & Medicals | 14.37 Million TWD | -218.15% |
| Level Biotechnology Inc. | 13.5 Million TWD | -238.72% |
| Medigen Vaccine Biologics Corporation | 1.97 Billion TWD | 97.684% |
| Meribank Biotech Co., Ltd | 34.03 Million TWD | -34.358% |
| Acepodia, Inc. | 273.81 Million TWD | 83.297% |
| Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | -123.551% |